Tag Archives: GVP

Top Tech Stocks To Watch Right Now

Instructure (NYSE:INST) stock dropped 13.6% in September, according to data from S&P Global Market Intelligence. For context, the S&P 500 edged up 0.6% last month.

The learning technology company’s stock has continued its downward movement this month, with shares declining 13.1% through Oct. 9. The broader market struggled during this period, with the S&P 500 falling 1.1% and the tech-heavy Nasdaq dropping 3.8%.

So far in 2018, Instructure stock has declined 7.1%, compared with the S&P 500’s 9.4% gain.

Image source: Getty Images.

So what

Instructure didn’t release any notable financial or business data during September, nor were there any significant news reports about it. So it’s probably safe to assume that the stock’s subpar performance was simply a continuation of the downward trend it’s been charting since the company released its second-quarter results on July 30. Both top and bottom line results slightly beat Wall Street’s estimates, along with the company’s guidance. However, the market punished the stock because the company’s third-quarter outlook was lighter than the Street was expecting. Shares lost 11.2% on July 31 and are in the red 29.4% since then.

Top Tech Stocks To Watch Right Now: 8×8 Inc(EGHT)

Advisors’ Opinion:

  • [By Max Byerly]

    Equities research analysts at William Blair started coverage on shares of 8X8 (NASDAQ:EGHT) in a research report issued to clients and investors on Wednesday, The Fly reports. The firm set a “buy” rating on the technology company’s stock.

  • [By Anders Bylund]

    Shares of cloud-based communications specialist 8×8 (NYSE:EGHT) crashed as much as 22.2% on Friday morning on the heels of a disappointing earnings report. At noon EDT, the stock had recovered to a 16% daily decline.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on 8X8 (EGHT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on 8X8 (EGHT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Tech Stocks To Watch Right Now: ArQule Inc.(ARQL)

Advisors’ Opinion:

  • [By Logan Wallace]

    ValuEngine downgraded shares of ArQule (NASDAQ:ARQL) from a strong-buy rating to a buy rating in a research report sent to investors on Saturday.

    Several other brokerages also recently issued reports on ARQL. Zacks Investment Research upgraded shares of ArQule from a hold rating to a buy rating and set a $2.75 target price for the company in a research note on Tuesday, May 8th. B. Riley set a $4.00 target price on shares of ArQule and gave the company a buy rating in a research note on Monday, March 26th. Roth Capital raised their target price on shares of ArQule from $5.00 to $6.00 and gave the company a buy rating in a research note on Tuesday, April 17th. BidaskClub upgraded shares of ArQule from a hold rating to a buy rating in a research note on Saturday, May 19th. Finally, Leerink Swann upgraded shares of ArQule from a market perform rating to an outperform rating in a research note on Thursday, April 5th. One research analyst has rated the stock with a sell rating, six have issued a buy rating and one has issued a strong buy rating to the company. The company has an average rating of Buy and a consensus price target of $5.35.

  • [By Cory Renauer]

    It isn’t unusual for oncology stocks to double in a single day after a company announces clinical trial results. Arqule (NASDAQ:ARQL) stands out among its peers because it notched a 67% gain after reporting a partial remission for just one leukemia patient.

  • [By Lisa Levin] Gainers
    Melinta Therapeutics, Inc. (NASDAQ: MLNT) shares surged 20.6 percent to $6.39. WBB Securities upgraded Melinta Therapeutics from Hold to Speculative Buy.
    Shoe Carnival, Inc. (NASDAQ: SCVL) shares climbed 17.2 percent to $30.87 after the company reported upbeat quarterly earnings.
    Acorn International, Inc. (NYSE: ATV) shares rose 15.2 percent to $28.804 after the company declared a special one-time cash dividend of $14.97 per ADS.
    Foot Locker, Inc. (NYSE: FL) gained 15 percent to $53.35 after the company reported better-than-expected results for its first quarter.
    Sears Hometown and Outlet Stores, Inc. (NASDAQ: SHOS) surged 14.2 percent to $2.625.
    ArQule, Inc. (NASDAQ: ARQL) rose 13 percent to $5.12 after gaining 4.86 percent on Thursday.
    Quality Systems, Inc. (NASDAQ: QSII) gained 12.8 percent to $16.97 after the company posted better-than-expected FQ4 results.
    Loma Negra Compañía Industrial Argentina Sociedad Anónima (NYSE: LOMA) shares rose 12 percent to $12.94.
    ArQule, Inc. (NASDAQ: ARQL) shares rose 12 percent to $5.07.
    Mirati Therapeutics, Inc. (NASDAQ: MRTX) climbed 11.4 percent to $43.50.
    Zai Lab Limited (NASDAQ: ZLAB) gained 11.3 percent to $24.7000.
    Zymeworks Inc. (NASDAQ: ZYME) rose 9.7 percent to $19.64.
    Park City Group, Inc. (NASDAQ: PCYG) climbed 9 percent to $7.90.
    Roku, Inc. (NASDAQ: ROKU) gained 7.9 percent to $38.82 after Citron reversed previously bearish position on the stock.
    Sears Holdings Corporation (NASDAQ: SHLD) shares jumped 7.3 percent to $3.55.
    Deckers Outdoor Corp (NYSE: DECK) rose 3.5 percent to $107.27 after reporting better-than-expected results for its fiscal fourth quarter.

    Check out these big penny stock gainers and losers

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on ArQule (ARQL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Tech Stocks To Watch Right Now: Cerner Corporation(CERN)

Advisors’ Opinion:

  • [By Keith Speights]

    As a result of Cerner Corporation’s (NASDAQ:CERN) weak first-quarter results, the company lowered its full-year 2018 outlook. The healthcare technology provider even projected that its second-quarter adjusted earnings could drop from the prior-year period.

  • [By Keith Speights]

    Cerner (NASDAQ:CERN) barely met its revenue guidance when the company reported its third-quarter results in October. Growth in its professional-services and managed-services businesses made the difference for the healthcare technology provider.

  • [By Steve Symington]

    But several individual stocks lagged the broader market. Read on to see why Cerner (NASDAQ:CERN), Biogen (NASDAQ:BIIB), and Alphabet (NASDAQ:GOOG)(NASDAQ:GOOGL) slumped today.

  • [By Jon C. Ogg]

    Cerner Corp. (NASDAQ: CERN) was raised to Buy from Neutral at Citigroup.

    Exxon Mobil Corp. (NYSE: XOM) was raised to Market Perform from Underperform at Raymond James.

  • [By Shane Hupp]

    Rockefeller Capital Management L.P. acquired a new position in shares of Cerner (NASDAQ:CERN) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 1,402,230 shares of the company’s stock, valued at approximately $81,329,000. Cerner comprises 1.3% of Rockefeller Capital Management L.P.’s portfolio, making the stock its 22nd largest holding.

  • [By Logan Wallace]

    Wilkins Investment Counsel Inc. boosted its holdings in Cerner (NASDAQ:CERN) by 14.9% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 18,650 shares of the company’s stock after purchasing an additional 2,425 shares during the quarter. Wilkins Investment Counsel Inc.’s holdings in Cerner were worth $1,082,000 as of its most recent SEC filing.

Top Tech Stocks To Watch Right Now: InterXion Holding N.V.(INXN)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Interxion (NYSE:INXN) had its price objective boosted by Citigroup from $68.00 to $75.00 in a research note issued to investors on Friday morning. Citigroup currently has a buy rating on the technology company’s stock.

  • [By Motley Fool Transcribers]

    Interxion Holding N.V  (NYSE:INXN)Q4 2018 Earnings Conference CallMarch 06, 2019, 8:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Shane Hupp]

    InterXion (NYSE:INXN) had its target price reduced by Credit Suisse Group from $70.00 to $69.00 in a report published on Thursday morning. They currently have an outperform rating on the technology company’s stock.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on InterXion (INXN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on InterXion (INXN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Tech Stocks To Watch Right Now: CVD Equipment Corporation(CVV)

Advisors’ Opinion:

  • [By Ethan Ryder]

    News headlines about CVD Equipment (NASDAQ:CVV) have trended somewhat positive recently, according to Accern. The research group identifies negative and positive media coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. CVD Equipment earned a media sentiment score of 0.05 on Accern’s scale. Accern also assigned news stories about the industrial products company an impact score of 46.7103888113407 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

  • [By Shane Hupp]

    News coverage about CVD Equipment (NASDAQ:CVV) has been trending somewhat positive this week, according to Accern. The research group ranks the sentiment of media coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. CVD Equipment earned a news impact score of 0.07 on Accern’s scale. Accern also assigned news headlines about the industrial products company an impact score of 47.2607770405573 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

Top Tech Stocks To Watch Right Now: GSE Systems, Inc.(GVP)

Advisors’ Opinion:

  • [By Stephan Byrd]

    GSE Systems (NYSEAMERICAN:GVP) SVP Daniel Warren Pugh sold 4,400 shares of the business’s stock in a transaction that occurred on Thursday, September 13th. The shares were sold at an average price of $3.75, for a total value of $16,500.00. Following the transaction, the senior vice president now owns 51,613 shares of the company’s stock, valued at approximately $193,548.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Best Heal Care Stocks To Own For 2019

One of the most asked (and most important) questions in energy has no simple answer: What’s the future of coal-fired power in the United States?

On one hand, recent history hasn’t been very favorable to coal. A little over a decade ago, coal-fired power plants produced more than half of the electricity in the United States. An unprecedented rate of plant retirements cut that share to just 30.1% in 2017. 

On the other hand, most of the coal plants shuttered in the last decade were smaller and older — and some were only used intermittently to begin with. It could prove more difficult to jettison newer, larger power plants from the American grid — which is a large factor in the U.S. Energy Information Administration’s forecast that coal could still generate as much as 22% of the country’s electricity in 2050. 

However, that number doesn’t seem quite right based on the planned pace of coal plant retirements by America’s largest utilities and power generators. In fact, it’s possible the United States may close most of its coal-fired power plants by 2040. Here’s why.

Best Heal Care Stocks To Own For 2019: Central Valley Community Bancorp(CVCY)

Advisors’ Opinion:

  • [By Max Byerly]

    These are some of the media headlines that may have effected Accern Sentiment’s scoring:

    Get Central Valley Community Bancorp alerts:

    Central Valley Community Bancorp (CVCY) Announces Dividend Increase – $0.08 Per Share (americanbankingnews.com) Is Central Valley Community Bancorp (CVCY) Outperforming Other Finance Stocks This Year? (finance.yahoo.com) Central Valley Community Bancorp announces stock repurchase plan (seekingalpha.com) Central Valley Community Bancorp Increases Quarterly Cash Dividend and Announces Stock Repurchase Plan (finance.yahoo.com) FY2018 EPS Estimates for Central Valley Community Bancorp Increased by Analyst (CVCY) (americanbankingnews.com)

    A number of equities analysts have recently commented on CVCY shares. Sandler O’Neill set a $24.00 price target on Central Valley Community Bancorp and gave the stock a “buy” rating in a report on Thursday, March 29th. ValuEngine lowered Central Valley Community Bancorp from a “buy” rating to a “hold” rating in a report on Monday, April 2nd. Zacks Investment Research downgraded Central Valley Community Bancorp from a “hold” rating to a “sell” rating in a research report on Friday, April 20th. Finally, BidaskClub downgraded Central Valley Community Bancorp from a “buy” rating to a “hold” rating in a research report on Monday, May 14th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the stock. The stock currently has an average rating of “Hold” and an average price target of $24.00.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Central Valley Community Bancorp (CVCY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Press coverage about Central Valley Community Bancorp (NASDAQ:CVCY) has trended somewhat negative on Monday, according to Accern Sentiment Analysis. Accern ranks the sentiment of press coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Central Valley Community Bancorp earned a daily sentiment score of -0.07 on Accern’s scale. Accern also gave media coverage about the financial services provider an impact score of 47.2059216377978 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

Best Heal Care Stocks To Own For 2019: The KEYW Holding Corporation(KEYW)

Advisors’ Opinion:

  • [By Shane Hupp]

    The Keyw (NASDAQ:KEYW) was upgraded by equities research analysts at ValuEngine from a “sell” rating to a “hold” rating in a research report issued on Friday.

  • [By Stephan Byrd]

    KEYW Holding Corp. (NASDAQ:KEYW) – Investment analysts at Seaport Global Securities issued their Q2 2018 earnings estimates for KEYW in a research report issued to clients and investors on Monday, July 16th. Seaport Global Securities analyst J. Sullivan expects that the software maker will earn ($0.20) per share for the quarter. Seaport Global Securities also issued estimates for KEYW’s FY2018 earnings at ($0.23) EPS.

  • [By Shane Hupp]

    The Keyw (NASDAQ: KEYW) and Leidos (NYSE:LDOS) are both computer and technology companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, valuation and dividends.

  • [By Max Byerly]

    Noble Financial reiterated their buy rating on shares of The Keyw (NASDAQ:KEYW) in a report issued on Tuesday morning. Noble Financial currently has a $11.00 target price on the software maker’s stock.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on KEYW (KEYW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Heal Care Stocks To Own For 2019: GSE Systems, Inc.(GVP)

Advisors’ Opinion:

  • [By Stephan Byrd]

    GSE Systems (NYSEAMERICAN:GVP) SVP Daniel Warren Pugh sold 4,400 shares of the business’s stock in a transaction that occurred on Thursday, September 13th. The shares were sold at an average price of $3.75, for a total value of $16,500.00. Following the transaction, the senior vice president now owns 51,613 shares of the company’s stock, valued at approximately $193,548.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Best Heal Care Stocks To Own For 2019: Zynga Inc.(ZNGA)

Advisors’ Opinion:

  • [By Steve Symington]

    Shares of Zynga Inc. (NASDAQ:ZNGA) were up 12.5% as of 3:15 p.m. EDT Tuesday after Bloomberg reported that the mobile games specialist is a potential acquisition target.

  • [By Logan Wallace]

    Zynga (NASDAQ:ZNGA) and Bilibili (NASDAQ:BILI) are both mid-cap consumer discretionary companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, risk, profitability, earnings, valuation and dividends.

  • [By Dan Caplinger]

    The stock market had another session of quiet trading on Tuesday, leaving most major benchmarks close to where they started. Declines early in the day gave way to more promising news from the bond market, where interest rates stabilized following last week’s big jump. Geopolitical and macroeconomic concerns continue to linger, and recent reports suggest weakening confidence in the prospects for global economic growth. Yet some companies benefited from good news that overcame the lackluster mood on Wall Street, and Zynga (NASDAQ:ZNGA), Pyxus International (NYSE:PYX), and Papa John’s International (NASDAQ:PZZA) were among the best performers on the day. Here’s why they did so well.

  • [By Anders Bylund]

    Gaming publishers are always looking for the next big thing. The odds of scoring a huge hit are vanishingly small, even for a short-term victory. Consider the case of Zynga (NASDAQ:ZNGA), the social gaming veteran that struck gold with FarmVille and Words With Friends once upon a time. The company went public at the very height of that adrenaline rush. If you bought in at Zynga’s peak share prices in the spring of 2012, you’ve weathered a 70% cut to your investment’s value so far. Like I said, it’s a long way down from the top.

  • [By Ethan Ryder]

    Zynga (NASDAQ:ZNGA) was upgraded by BidaskClub from a “strong sell” rating to a “sell” rating in a research note issued on Friday.

Best Heal Care Stocks To Own For 2019: Blackhawk Network Holdings, Inc.(HAWK)

Advisors’ Opinion:

  • [By Max Byerly]

    Shares of Blackhawk Network Holdings (NASDAQ:HAWK) have been given a consensus rating of “Hold” by the eighteen ratings firms that are presently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, fourteen have assigned a hold recommendation and two have given a buy recommendation to the company. The average twelve-month target price among brokers that have covered the stock in the last year is $44.75.

Best Heal Care Stocks To Own For 2019: Myers Industries, Inc.(MYE)

Advisors’ Opinion:

  • [By Max Byerly]

    Newell Brands (NYSE: NWL) and Myers Industries (NYSE:MYE) are both consumer staples companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, profitability, earnings, institutional ownership, valuation and dividends.

  • [By Motley Fool Transcribers]

    Myers Industries Inc.  (NYSE:MYE)Q4 2018 Earnings Conference CallFeb. 28, 2019, 8:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Myers Industries (MYE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Blue Chip Stocks To Watch For 2019

During these busy times, it pays to stay on top of the latest profit opportunities, and today’s blog post is a great place to start.

After taking a close look at the latest data on institutional buying pressure and each company’s fundamental health, I decided to revise my Portfolio Grader recommendations for 113 big blue chips.

Chances are that you have at least one of these stocks in your portfolio, so you may want to give this list a skim and act accordingly.

This Week’s Ratings Changes:

Top 10 Blue Chip Stocks To Watch For 2019: Town Sports International Holdings, Inc.(CLUB)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Town Sports International (CLUB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Town Sports International Holdings, Inc. (NASDAQ:CLUB) hit a new 52-week high during mid-day trading on Monday . The stock traded as high as $14.85 and last traded at $14.22, with a volume of 6778 shares traded. The stock had previously closed at $14.65.

  • [By Stephan Byrd]

    ClubCoin (CLUB) is a PoW/PoS coin that uses the
    Proof of Stake hashing algorithm. Its genesis date was October 21st, 2015. ClubCoin’s total supply is 99,422,559 coins. ClubCoin’s official Twitter account is @clubcoin_co and its Facebook page is accessible here. The official website for ClubCoin is clubcoin.co.

  • [By Stephan Byrd]

    ClubCoin (CURRENCY:CLUB) traded 1.9% higher against the US dollar during the twenty-four hour period ending at 0:00 AM Eastern on February 2nd. One ClubCoin coin can now be purchased for about $0.37 or 0.00010522 BTC on popular exchanges including Trade Satoshi and YoBit. ClubCoin has a market capitalization of $0.00 and $15,235.00 worth of ClubCoin was traded on exchanges in the last day. During the last seven days, ClubCoin has traded down 5.3% against the US dollar.

  • [By Logan Wallace]

    ClubCoin (CURRENCY:CLUB) traded up 18.2% against the dollar during the one day period ending at 16:00 PM E.T. on July 20th. One ClubCoin coin can now be purchased for about $0.66 or 0.00009000 BTC on exchanges. In the last seven days, ClubCoin has traded up 41.8% against the dollar. ClubCoin has a total market capitalization of $0.00 and $11,282.00 worth of ClubCoin was traded on exchanges in the last day.

  • [By Shane Hupp]

    ClubCoin (CURRENCY:CLUB) traded up 24.9% against the dollar during the 1 day period ending at 10:00 AM Eastern on August 28th. One ClubCoin coin can currently be purchased for approximately $0.63 or 0.00008900 BTC on cryptocurrency exchanges. In the last seven days, ClubCoin has traded 78.8% higher against the dollar. ClubCoin has a total market capitalization of $0.00 and approximately $67,516.00 worth of ClubCoin was traded on exchanges in the last day.

Top 10 Blue Chip Stocks To Watch For 2019: GSE Systems, Inc.(GVP)

Advisors’ Opinion:

  • [By Stephan Byrd]

    GSE Systems (NYSEAMERICAN:GVP) SVP Daniel Warren Pugh sold 4,400 shares of the business’s stock in a transaction that occurred on Thursday, September 13th. The shares were sold at an average price of $3.75, for a total value of $16,500.00. Following the transaction, the senior vice president now owns 51,613 shares of the company’s stock, valued at approximately $193,548.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Top 10 Blue Chip Stocks To Watch For 2019: Applied Materials, Inc.(AMAT)

Advisors’ Opinion:

  • [By Logan Wallace]

    Ostrum Asset Management lifted its holdings in shares of Applied Materials, Inc. (NASDAQ:AMAT) by 214.5% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 17,386 shares of the manufacturing equipment provider’s stock after buying an additional 11,857 shares during the period. Ostrum Asset Management’s holdings in Applied Materials were worth $967,000 at the end of the most recent quarter.

  • [By Garrett Baldwin]

    Crude oil prices continue to remain in focus after Brent crude hit $80.00 per barrel. The benchmark crude touched $80.00, as markets are concerned about the impact renewed Iranian sanctions will have on global supply. French oil giant Total announced Wednesday that it was abandoning a gas project in Iran after failing to obtain a waiver from the Trump administration to do business in Iran. The sanctions are expected to decline global output at a time that OPEC is already working diligently to push oil prices higher by containing excessive global production.
    Four Stocks to Watch Today: JCP, BABA, F, KR
    Shares of JCPenney (NYSE: JCP) are ticking higher after its earnings report before the bell. Yesterday, retail companies were stunned by the 11% jump for its rival Macy’s Inc. (NYSE: M) stock thanks to a strong first-quarter report. Alibaba Group Holding Ltd. (NYSE: BABA) is generating a lot of buzz as investors monitor trade relations between the United States and China. BABA stock had slumped by 18% thanks to trade restrictions on Chinese companies. Ford Motor Co. (NYSE: F) announced it will restart production of its popular F-150 pickup truck at its Dearborn, Mich., facility. The company recently suspended operations after a fire damaged supplies needed for manufacturing. The F-150 is the most popular consumer vehicle in the United States. In an effort to beat back the growth of Wal-Mart and Amazon, grocery giant Kroger Co. (NYSE: KR) announced a deal to purchase a 5% stake in British online supermarket Ocado. The deal will allow Kroger to utilize the UK firm’s warehouse automation technology in the United States and improve its supply chain costs. Look for additional earnings reports from Applied Materials Inc. (Nasdaq: AMAT), Nordstrom Inc. (NYSE: JWN), The Children’s Place Inc. (Nasdaq: PLCE), Teekay Corp. (NYSE: TK), and Quantum Corp. (NYSE: QTM).

    Follow Money Morning on Facebook, Twitter, and LinkedIn.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    ReTo Eco-Solutions, Inc. (NASDAQ: RETO) fell 9.3 percent to $4.50 in pre-market trading.
    ProPhase Labs, Inc. (NASDAQ: PRPH) shares fell 8.5 percent to $4.50 in pre-market trading after dropping 3.53 percent on Thursday.
    Nordstrom, Inc. (NYSE: JWN) fell 7.5 percent to $47.10 in pre-market trading. Nordstrom reported upbeat results for its first quarter. Comparable-store sales rose 0.6 percent.
    Baidu, Inc. (NASDAQ: BIDU) shares fell 6 percent to $263.00 in pre-market trading. Baidu disclosed that its COO Qi Lu will step down in July 2018.
    Riot Blockchain, Inc. (NASDAQ: RIOT) shares fell 5.6 percent to $8.98 in pre-market trading after climbing 11.88 percent on Thursday.
    Applied Materials, Inc. (NASDAQ: AMAT) fell 5 percent to $51.30 in pre-market trading. Applied Materials reported stronger-than-expected results for its second quarter, but issued weak sales outlook for the third quarter.
    Blink Charging Co. (NASDAQ: BLNK) fell 5 percent to $7.61 in pre-market trading after rising 11.40 percent on Thursday.
    Illumina, Inc. (NASDAQ: ILMN) shares fell 4.7 percent to $255.77 in pre-market trading.
    Vascular Biogenics Ltd (NASDAQ: VBLT) fell 4.6 percent to $2.10 in pre-market trading after reporting a first-quarter earnings miss.
    Campbell Soup Company (NYSE: CPB) fell 3.3 percent to $37.60 in pre-market trading. Campbell Soup reported upbeat Q3 earnings, but sales missed estimates. The company also lowered its FY18 outlook.
    ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) shares fell 2.7 percent to $17.65 in pre-market trading after reporting a 7.2 million common stock offering

  • [By Chris Lange]

    Short interest in Applied Materials Inc. (NASDAQ: AMAT) fell to 16.35 million shares. The previous reading was 18.30 million. Shares were trading at $45.20, in a 52-week range of $41.94 to $62.40.

Top 10 Blue Chip Stocks To Watch For 2019: iAnthus Capital Holdings, Inc. (ITHUF)

Advisors’ Opinion:

  • [By Sean Williams]

    It’s not even just a Canadian problem. iAnthus Capital Holdings (NASDAQOTH:ITHUF), a vertically integrated cannabis dispensary with a focus on the U.S. market, recently closed on its purchase of MPX Bioceutical. This roughly $600 million deal increases the number of states iAnthus has access to from six to 11, and lifts its retail license count to 63. But take a gander at its most recent quarterly filing and you’ll see that CA$7.2 million in goodwill has not so magically transformed into CA$75.9 million in goodwill over a nine-month period, through Sept. 30, 2018. This represents 55% of the company’s total assets.

  • [By Keith Speights]

    Marijuana grower

    Canopy Growth Corporation (NYSE:CGC) $5.8 billion
      Aurora Cannabis (NASDAQOTH: ACBFF) $2.9 billion
      Tilray (NASDAQ: TLRY) $2.3 billion
      Aphria (NASDAQOTH: APHQF) $1.9 billion
      MedMen Enterprises (NASDAQOTH: MMNFF) $1.3 billion
      Cronos Group (NASDAQ: CRON) $1 billion
      The Green Organic Dutchman (NASDAQOTH: TGODF) $1 billion
      The Hydropothecary (NASDAQOTH: HYYDF) $728 million
      CannTrust Holdings (NASDAQOTH: CNTTF) $513 million
      Organigram Holdings (NASDAQOTH: OGRMF) $509 million
      Marimed (NASDAQOTH: MRMD) $472 million
      TerrAscend (NASDAQOTH: TRSSF) $398 million
      Auxly Cannabis (NASDAQOTH: CBWTF) $368 million
      iAnthus Capital Holdings (NASDAQOTH: ITHUF) $367 million
      Medical Marijuana (NASDAQOTH: MJNA) $330 million
      CV Sciences (NASDAQOTH: CVSI) $299 million
      Emerald Health Therapeutics (NASDAQOTH: EMHTF) $287 million
      Supreme Cannabis (NASDAQOTH: SPRWF) $277 million
      Smart Cannabis (NASDAQOTH: SCNA) $276 million
      MPX Bioceutical (NASDAQOTH: MPXEF) $234 million
      AusCann Group Holdings (NASDAQOTH: ACNNF) $223 million
      Liberty Health Sciences (NASDAQOTH: LHSIF) $213 million

    Biotech

  • [By Sean Williams]

    For instance, iAnthus Capital Holding (NASDAQOTH:ITHUF) recently completed the largest U.S. deal to date by purchasing MPX Bioceutical for around $600 million. (This deal will be eclipsed by MedMen’s purchase of PharmaCann, once that deal closes.) Though it’s unclear what sort of premium iAnthus paid for MPX Bioceutical as of yet, a quick glance at iAnthus Capital’s balance sheet shows that 55% of its total assets are currently tied up in goodwill. Since the dispensary space will presumably have plenty of competition, it’s unclear if iAnthus (or other acquisition-hungry dispensaries) will be able to recoup the premium it’s paid to buy other businesses. This leaves the door open for hefty future writedowns.

Top 10 Blue Chip Stocks To Watch For 2019: United Microelectronics Corporation(UMC)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Here are some of the media stories that may have effected Accern’s analysis:

    Get UMC alerts:

    UMC – United Microelectronics Corporation: UMC Shareholders Elect 14th Term of Directors at Annual Shareholders Meeting (twst.com) UPDATE: Bernstein Upgrades United Microelectronics (UMC) to Market Perform (streetinsider.com) UMC’s new burn center fills three-decade need in New Orleans (neworleanscitybusiness.com) Community breakfast at Sparta UMC is open to all (mlive.com) Shopper News blog: Beaver Ridge UMC youth — ‘we’re there to help’ (knoxnews.com)

    A number of brokerages recently commented on UMC. Sanford C. Bernstein upgraded shares of UMC from an “underperform” rating to a “market perform” rating and lifted their target price for the stock from $2.10 to $2.60 in a research report on Sunday. ValuEngine cut shares of UMC from a “buy” rating to a “hold” rating in a research report on Thursday, April 26th. Six investment analysts have rated the stock with a sell rating, four have given a hold rating, two have assigned a buy rating and one has issued a strong buy rating to the company’s stock. UMC presently has an average rating of “Hold” and a consensus price target of $2.60.

  • [By Max Byerly]

    Shares of United Microelectronics Corp (NYSE:UMC) have received a consensus rating of “Hold” from the ten analysts that are currently covering the stock, Marketbeat.com reports. Five investment analysts have rated the stock with a sell recommendation and five have given a hold recommendation to the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $2.19.

  • [By Money Morning News Team]

    United Microelectronics Corp. (NYSE: UMC) is a semiconductor company based in Hsinchu, Taiwan.

    Founded as Taiwan’s first semiconductor company in 1980, UMC is best known for manufacturing integrated circuits used by larger semiconductor companies like Nvidia Corp. (Nasdaq: NVDA) in their products.

Top 10 Blue Chip Stocks To Watch For 2019: Energy Transfer Equity, L.P.(ETE)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    Like last quarter, Energy Transfer Partners delivered strong earnings and cash flow growth. Because of that, the company was able to cover its jaw-dropping 12.4%-yielding distribution by a healthy 1.15 times. That slight decline from the year-ago quarter was caused by parent company Energy Transfer Equity (NYSE:ETE) significantly reducing its support. For a better comparison, the coverage ratio would have still been a solid 1.1 in this year’s first quarter without any assistance from Energy Transfer Equity, while it would have been a worrisome 0.98 in the year-ago period without the parent company’s help. That improvement is exactly what investors wanted to see this quarter.

  • [By Lee Jackson]

    This MLP brings the potential for solid growth and income. Energy Transfer Equity LP (NYSE: ETE) owns the general partner and 100% of the incentive distribution rights (IDRs) of Energy Transfer Partners and Sunoco. The company also owns Lake Charles LNG. On a consolidated basis, the family of companies owns and operates a diverse portfolio of natural gas, natural gas liquids (NGLs), crude oil and refined products assets, as well as retail and wholesale motor fuel operations and liquefied natural gas terminaling.

  • [By Logan Wallace]

    Goldman Sachs Group assumed coverage on shares of Energy Transfer Equity LP Unit (NYSE:ETE) in a report released on Monday morning, MarketBeat reports. The brokerage issued a buy rating and a $23.00 target price on the pipeline company’s stock.

Top 10 Blue Chip Stocks To Watch For 2019: VSE Corporation(VSEC)

Advisors’ Opinion:

  • [By Logan Wallace]

    Stantec (NYSE: STN) and VSE (NASDAQ:VSEC) are both business services companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, valuation, profitability, earnings, risk, institutional ownership and analyst recommendations.

  • [By Money Morning Staff Reports]

    Caterpillar Inc. (NYSE: CAT) will increase its dividend forward yield by 10.26%, VSE Corp. (Nasdaq: VSEC) will increase its dividend payout by 14.29%, and PNC Financial Services Group Inc. (NYSE: PNC) will increase its dividend payout by 26.67%.

  • [By Tyler Crowe, Rich Smith, and Daniel Miller]

    In the spirit of Lynch’s investment principles, we asked three of our Motley Fool investors to each highlight a stock Wall Street isn’t paying much attention to, but could be a great investment. Here’s a brief look at their selections: WD-40 Company (NASDAQ:WDFC), Control4 (NASDAQ:CTRL), and VSE Corporation (NASDAQ:VSEC). 

Top 10 Blue Chip Stocks To Watch For 2019: AVG Technologies N.V.(AVG)

Advisors’ Opinion:

  • [By Shane Hupp]

    FinnCap cut shares of Avingtrans (LON:AVG) to a corporate rating in a research report report published on Monday.

    Shares of LON:AVG opened at GBX 223 ($2.97) on Monday. Avingtrans has a one year low of GBX 174.11 ($2.32) and a one year high of GBX 260 ($3.46).

Top 10 Blue Chip Stocks To Watch For 2019: Madrigal Pharmaceuticals, Inc. (MDGL)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares surged 144.96 percent to close at $265.61 on Thursday in reaction to an encouraging Phase 2 clinical trial update. The clinical-stage biopharmaceutical company said its liver-directed, thyroid hormone receptor called MGL-3196 showed a statistical significance in the primary endpoint of lowering liver fat at 12 weeks and also 36 weeks.
    Viking Therapeutics, Inc. (NASDAQ: VKTX) shares rose 101.01 percent to close at $9.99 on Thursday after falling 4.42 percent on Wednesday.
    Akers Biosciences, Inc. (NASDAQ: AKER) jumped 45.58 percent to close at $0.474. The developer of rapid health information technologies said Wednesday afternoon it was granted a 180-day extension from the Nasdaq Stock Market to meet the requirement of a minimum $1.00 per share closing bid price for 10 straight days.
    Kitov Pharma Ltd (NASDAQ: KTOV) gained 40.93 percent to close at $3.03 after the FDA approved Kitov's Consensi for the treatment of osteoarthritis pain and hypertension.
    China Customer Relations Centers, Inc. (NASDAQ: CCRC) rose 28.21 percent to close at $19.86.
    J.Jill, Inc. (NYSE: JILL) climbed 26.45 percent to close at $7.84 after the company posted upbeat quarterly earnings.
    Curis, Inc. (NASDAQ: CRIS) shares climbed 21.93 percent to close at $2.78 in reaction to an encouraging FDA update. The biotechnology company that focuses on therapies for the treatment of cancer said the FDA granted a Fast Track designation for fimepinostat (CUDC-907) in patients with relapsed or refractory.
    Boxlight Corporation (NASDAQ: BOXL) gained 21.23 percent to close at $7.48.
    Kirkland's, Inc. (NASDAQ: KIRK) rose 16.21 percent to close at $12.83 after reporting upbeat Q1 results.
    The Brink's Company (NYSE: BCO) jumped 16.2 percent to close at $79.25 as the company announced plans to acquire Dunbar Armored for $520 million in cash.
    Applied Optoelectronics, Inc. (NASDAQ: AAOI) rose 15.14 percent to c
  • [By Sean Williams, Chuck Saletta, and Brian Feroldi]

    In recent weeks, a couple of under-the-radar players have wowed Wall Street. Less than three weeks ago, Madrigal Pharmaceuticals (NASDAQ:MDGL) reported top-line results from its 36-week phase 2 study involving MGL-3196 as a treatment for NASH. Overall, Madrigal’s liver biopsy results showed that 70% of patients with a more than 30% fat reduction at week 12 demonstrated a greater than two-point reduction in their NAFLD Activity Score by the 36th week. That was more than double the 32% of patients that demonstrated a similar response by taking the placebo. 

  • [By Joseph Griffin]

    Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) was the target of unusually large options trading on Tuesday. Traders acquired 1,068 call options on the stock. This is an increase of approximately 1,404% compared to the typical daily volume of 71 call options.

Top 10 Blue Chip Stocks To Watch For 2019: BlackRock Utility and Infrastructure Trust(BUI)

Advisors’ Opinion:

  • [By Logan Wallace]

    Blackrock Utlts Infra&Pwr Oprtnt Trst (NYSE:BUI) announced a monthly dividend on Monday, October 1st, NASDAQ reports. Shareholders of record on Monday, October 15th will be paid a dividend of 0.121 per share by the real estate investment trust on Wednesday, October 31st. This represents a $1.45 dividend on an annualized basis and a yield of 7.26%. The ex-dividend date is Friday, October 12th.

  • [By Ethan Ryder]

    Media stories about Blackrock Utlts Infra&Pwr Oprtnt Trst (NYSE:BUI) have trended somewhat negative this week, Accern reports. The research group identifies negative and positive press coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Blackrock Utlts Infra&Pwr Oprtnt Trst earned a media sentiment score of 0.00 on Accern’s scale. Accern also gave headlines about the real estate investment trust an impact score of 47.3004100251897 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

  • [By Joseph Griffin]

    Blackrock Utlts Infra&Pwr Oprtnt Trst (NYSE:BUI) declared a monthly dividend on Wednesday, August 1st, NASDAQ reports. Investors of record on Wednesday, August 15th will be given a dividend of 0.121 per share by the real estate investment trust on Friday, August 31st. This represents a $1.45 annualized dividend and a yield of 7.02%. The ex-dividend date of this dividend is Tuesday, August 14th.

  • [By Ethan Ryder]

    News headlines about Blackrock Utlts Infra&Pwr Oprtnt Trst (NYSE:BUI) have trended somewhat positive on Sunday, Accern Sentiment Analysis reports. Accern ranks the sentiment of press coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Blackrock Utlts Infra&Pwr Oprtnt Trst earned a news impact score of 0.00 on Accern’s scale. Accern also assigned news articles about the real estate investment trust an impact score of 47.4349959781156 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

  • [By Logan Wallace]

    Raymond James Financial Services Advisors Inc. lifted its position in shares of Blackrock Utlts Infra&Pwr Oprtnt Trst (NYSE:BUI) by 23.6% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 41,436 shares of the real estate investment trust’s stock after buying an additional 7,911 shares during the quarter. Raymond James Financial Services Advisors Inc. owned approximately 0.24% of Blackrock Utlts Infra&Pwr Oprtnt Trst worth $829,000 at the end of the most recent quarter.

Top 10 Medical Stocks To Watch For 2019

Haemonetics Co. (NYSE:HAE) – Equities researchers at William Blair reduced their Q2 2019 earnings estimates for Haemonetics in a research report issued on Tuesday, August 7th. William Blair analyst B. Weinstein now expects that the medical instruments supplier will post earnings per share of $0.55 for the quarter, down from their prior estimate of $0.56. William Blair also issued estimates for Haemonetics’ Q3 2019 earnings at $0.58 EPS.

Get Haemonetics alerts:

Haemonetics (NYSE:HAE) last announced its quarterly earnings results on Tuesday, August 7th. The medical instruments supplier reported $0.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.42 by $0.17. The company had revenue of $229.35 million for the quarter, compared to the consensus estimate of $219.52 million. Haemonetics had a net margin of 2.45% and a return on equity of 15.00%.

Top 10 Medical Stocks To Watch For 2019: GSE Systems, Inc.(GVP)

Advisors’ Opinion:

  • [By Stephan Byrd]

    GSE Systems (NYSEAMERICAN:GVP) SVP Daniel Warren Pugh sold 4,400 shares of the business’s stock in a transaction that occurred on Thursday, September 13th. The shares were sold at an average price of $3.75, for a total value of $16,500.00. Following the transaction, the senior vice president now owns 51,613 shares of the company’s stock, valued at approximately $193,548.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Top 10 Medical Stocks To Watch For 2019: ePlus Inc.(PLUS)

Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    ePlus Inc  (NASDAQ:PLUS)Q3 2019 Earnings Conference CallFeb. 06, 2019, 4:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Stephan Byrd]

    ePlus (NASDAQ:PLUS) Director Eric D. Hovde sold 27,995 shares of the firm’s stock in a transaction on Wednesday, June 6th. The stock was sold at an average price of $94.23, for a total value of $2,637,968.85. Following the transaction, the director now owns 23,301 shares in the company, valued at $2,195,653.23. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

  • [By Max Byerly]

    Uniplan Investment Counsel Inc. reduced its stake in ePlus (NASDAQ:PLUS) by 1.1% during the 1st quarter, HoldingsChannel reports. The fund owned 116,594 shares of the software maker’s stock after selling 1,335 shares during the period. Uniplan Investment Counsel Inc.’s holdings in ePlus were worth $9,059,000 at the end of the most recent reporting period.

  • [By Ethan Ryder]

    Tech Data (NASDAQ: TECD) and ePlus (NASDAQ:PLUS) are both retail/wholesale companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, institutional ownership, risk, dividends, analyst recommendations, profitability and earnings.

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    Ross Stores, Inc. (NASDAQ: ROST) is projected to post quarterly earnings at $1.07 per share on revenue of $3.54 billion.
    Autodesk, Inc. (NASDAQ: ADSK) is expected to post quarterly earnings at $0.03 per share on revenue of $557.65 million.
    Gap, Inc. (NYSE: GPS) is projected to post quarterly earnings at $0.46 per share on revenue of $3.60 billion.
    Quality Systems, Inc. (NASDAQ: QSII) is estimated to post quarterly earnings at $0.13 per share on revenue of $131.95 million.
    Splunk Inc. (NASDAQ: SPLK) is expected to post quarterly loss at $0.09 per share on revenue of $297.67 million.
    Shoe Carnival, Inc. (NASDAQ: SCVL) is projected to post quarterly earnings at $0.71 per share on revenue of $262.02 million.
    Deckers Outdoor Corporation (NYSE: DECK) is expected to post quarterly earnings at $0.19 per share on revenue of $375.41 million.
    Zoe's Kitchen, Inc. (NYSE: ZOES) is estimated to post quarterly loss at $0.01 per share on revenue of $105.30 million.
    DXC Technology Company (NYSE: DXC) is expected to post quarterly earnings at $2.23 per share on revenue of $6.12 billion.
    8×8, Inc. (NASDAQ: EGHT) is estimated to post quarterly loss at $0.05 per share on revenue of $76.93 million.
    Viasat, Inc. (NASDAQ: VSAT) is projected to post quarterly loss at $0.45 per share on revenue of $424.46 million.
    ePlus inc. (NASDAQ: PLUS) is estimated to post quarterly earnings at $1.01 per share on revenue of $1.60 billion.
    Lions Gate Entertainment Corp. (NYSE: LGF.A) is expected to post quarterly loss at $0.04 per share on revenue of $1.04 billion.
    Agilysys, Inc. (NASDAQ: AGYS) is estimated to post quarterly loss at $0.08 per share on revenue of $32.58 million.
    Nutanix, Inc. (NASDAQ: NTNX) is estimated to post quarterly loss at $0.19 per share on revenue of $278.98 million.
    Veeva Systems Inc. (NYSE: VEEV) is projected to post quarterly earnings at $0.31 per share on revenue

Top 10 Medical Stocks To Watch For 2019: Innovative Industrial Properties, Inc. (IIPR)

Advisors’ Opinion:

  • [By Sean Williams]

    Lastly, this marijuana skeptic likes Innovative Industrial Properties (NYSE:IIPR), a U.S.-based real estate investment trust (REIT).

    The beauty of the REIT model is that it tends to produce predictable cash flow at roughly fixed costs. A REIT will acquire land and buildings within a specific industry of focus, then look to lease these assets out for a long period of time. Later, these assets can be disposed of for a profit, should the REIT choose.

  • [By Dan Caplinger]

    Marijuana stocks have become exceedingly popular, but not everyone feels comfortable investing directly in the companies that produce and grow cannabis. Instead, some prefer to look at the companies that are in the business of helping marijuana producers maximize their growth business. Scotts Miracle-Gro (NYSE:SMG) provides fertilizers and equipment that individual and commercial operations can use to boost cannabis production, while Innovative Industrial Properties (NYSE:IIPR) is a real estate investment trust designed to help cannabis companies find the space they need while meeting all the regulatory requirements surrounding marijuana production facilities.

  • [By Keith Speights]

    Canopy Growth wouldn’t be the first cannabis-focused REIT if it decides to move forward with Linton’s idea. Innovative Industrial Properties (NYSE:IIPR) owns properties in 10 U.S. states. It leases these properties to businesses operating in the medical cannabis industry.

  • [By Keith Speights]

    Two cannabis-focused biotechs, Insys Pharmaceuticals (NASDAQ:INSY) and GW Pharmaceuticals (NASDAQ:GWPH), ranked among the five best-performing marijuana stocks last month. CannTrust Holdings (NYSE:CTST) and Village Farms International (NASDAQ:VFF) made the list for February but aren’t in the top tier of Canadian marijuana producers. And one U.S.-based company that isn’t a biotech landed in the top five as well — Innovative Industrial Properties (NYSE:IIPR).

  • [By Dan Caplinger]

    The stock market jumped on Friday, sending the Dow Jones Industrial Average to gains of over 400 points as investors seemed pleased with news out of Washington. The federal government averted another potential shutdown, and building positive momentum made some market participants fearful that they could miss out if stock indexes keep heading upward toward record levels. Some positive news on the earnings front for certain high-profile stocks also improved sentiment. Arista Networks (NYSE:ANET), Talend (NASDAQ:TLND), and Innovative Industrial Properties (NYSE:IIPR) were among the top performers. Here’s why they did so well.

Top 10 Medical Stocks To Watch For 2019: Banco De Chile(BCH)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Shares of Banco de Chile (NYSE:BCH) have been given a consensus recommendation of “Sell” by the seven analysts that are currently covering the stock, MarketBeat.com reports. Five investment analysts have rated the stock with a sell recommendation and two have assigned a hold recommendation to the company. The average twelve-month price objective among brokers that have issued a report on the stock in the last year is $91.00.

  • [By Max Byerly]

    Bitcoin Cash (CURRENCY:BCH) traded 3.3% lower against the US dollar during the one day period ending at 23:00 PM E.T. on August 25th. One Bitcoin Cash coin can now be bought for about $520.83 or 0.07863301 BTC on popular exchanges including Mercatox, BTCC, Bit2C and xBTCe. Bitcoin Cash has a market capitalization of $9.02 billion and approximately $268.90 million worth of Bitcoin Cash was traded on exchanges in the last day. Over the last week, Bitcoin Cash has traded down 5.9% against the US dollar.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Banco de Chile (BCH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Bitcoin Cash (CURRENCY:BCH) traded down 1.5% against the dollar during the 24 hour period ending at 19:00 PM E.T. on May 19th. During the last week, Bitcoin Cash has traded down 18.1% against the dollar. One Bitcoin Cash coin can now be bought for $1,184.65 or 0.14390800 BTC on major exchanges including fex, Koinex, DSX and Bitfinex. Bitcoin Cash has a total market cap of $20.30 billion and approximately $598.31 million worth of Bitcoin Cash was traded on exchanges in the last 24 hours.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Banco de Chile (BCH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Banco de Chile (NYSE: BCH) and Cr AGRICOLE S A/ADR (OTCMKTS:CRARY) are both large-cap finance companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, earnings, profitability, dividends, analyst recommendations and institutional ownership.

Top 10 Medical Stocks To Watch For 2019: Koss Corporation(KOSS)

Advisors’ Opinion:

  • [By Money Morning Staff Reports]

    However, Seven Star’s gains are already on the books. After looking at last week’s top performing penny stocks, we’ll show you a penny stock on the verge of jumping over 70%…

    Penny Stock Current Share Price Last Week’s Gain
    Seven Stars Cloud Group Inc. (Nasdaq: SSC) $4.49 175.13%
    Alliance MMA Inc. (Nasdaq: AMMA) $0.37 121.05%
    India Globalization Capital Inc. (NYSE: IGC) $1.14 74.38%
    Obalon Therapeutics Inc. (Nasdaq: OBLN) $3.23 63.16%
    Cytori Therapeutics Inc. (Nasdaq: CYTX) $0.56 55.76%
    Atlanticus Holdings Corp. (Nasdaq: ATLC) $2.85 43.55%
    Research Frontiers Inc. (Nasdaq: REFR) $1.28 41.37%
    Koss Corp. (Nasdaq: KOSS) $4.08 41.28%
    GLG Life Tech Corp. (TSE: GLG) $0.88 33.90%
    Geron Corp. (Nasdaq: GERN) $4.76 32.40%

    While those gains are already in the book, you don’t have to miss out on the next penny stocks to soar.

  • [By Lisa Levin] Gainers
    Stellar Biotechnologies, Inc. (NASDAQ: SBOT) rose 32 percent to $2.89 in pre-market trading after the company disclosed that it achieved robust viral clearance for its manufacturing process.
    Babcock & Wilcox Enterprises, Inc. (NYSE: BW) rose 17.7 percent to $3.03 in pre-market trading after an amended 13D filing from Steel Partners Holdings shows a raised stake in the company from 6.99 million shares to 29.98 million shares, or a 17.8 percent stake.
    AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) shares rose 12.7 percent to $3.55 in pre-market trading after the company announced the FDA acceptance of NDA for DSUVIA.
    Williams-Sonoma, Inc. (NYSE: WSM) shares rose 11.7 percent to $54.95 in pre-market trading. after the company reported stronger-than-expected results for its first quarter. The company also raised its FY18 earnings and sales guidance.
    Bilibili Inc. (NASDAQ: BILI) shares rose 9.3 percent to $13.59 in pre-market trading after announcing Q1 results.
    Stein Mart, Inc. (NASDAQ: SMRT) rose 8.1 percent to $3.46 in pre-market trading after reporting strong Q1 earnings.
    Universal Corporation (NYSE: UVV) rose 8.1 percent to $52.35 in pre-market trading after reporting fiscal Q4 results.
    Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) rose 8.1 percent to $5.65 in pre-market trading after gaining 6.30 percent on Wednesday.
    CEL-SCI Corporation (NYSE: CVM) rose 6.1 percent to $3.30 in pre-market trading after climbing 9.51 percent on Wednesday.
    TransEnterix, Inc. (NYSE: TRXC) rose 6 percent to $3.10 in pre-market trading after reporting a loan deal for $40 million in term loans with Hercules Capital.
    Stage Stores, Inc. (NYSE: SSI) rose 5.6 percent to $3.40 in pre-market trading following Q1 results.
    Koss Corporation (NASDAQ: KOSS) shares rose 5.2 percent to $2.42 in the pre-market trading session after falling 2.54 percent on Wednesday.

     

  • [By Lisa Levin] Gainers
    Loxo Oncology, Inc. (NASDAQ: LOXO) rose 17.1 percent to $163.30 in pre-market trading as the company disclosed that LOXO-292 Phase 1 trial abstract was selected for 'Best of ASCO'.
    CytomX Therapeutics, Inc. (NASDAQ: CTMX) rose 11.5 percent to $27.15 in pre-market trading after the company announced presentations at the 2018 ASCO Annual Meeting.
    Check-Cap Ltd. (NASDAQ: CHEK) rose 12.3 percent to $5.47 in pre-market trading after reporting narrower-than-expected Q1 loss.
    Flotek Industries, Inc. (NYSE: FTK) shares rose 7.1 percent to $3.62 in the pre-market trading session.
    Baozun Inc. (NASDAQ: BZUN) shares rose 5.8 percent to $47.65 in pre-market trading after reporting Q1 results.
    World Wrestling Entertainment, Inc. (NYSE: WWE) rose 5.5 percent to $46.00 in pre-market trading.
    Williams Partners L.P. (NYSE: WPZ) rose 5.3 percent to $40.50 in pre-market trading after The Williams Companies, Inc. (NYSE: WMB) announced agreement to acquire all public equity of Williams Partners in a $10.5 billion deal.
    Koss Corporation (NASDAQ: KOSS) shares rose 4.6 percent to $2.72 in pre-market trading after surging 12.55 percent on Wednesday.
    Enphase Energy, Inc. (NASDAQ: ENPH) rose 4.5 percent to $5.85 in pre-market trading after gaining 5.66 percent on Wednesday.
    Farmer Bros. Co. (NASDAQ: FARM) rose 4.1 percent to $27 in pre-market trading after climbing 7.90 percent on Wednesday.
    Kosmos Energy Ltd. (NYSE: KOS) rose 4 percent to $7.70 in pre-market trading.

     

Top 10 Medical Stocks To Watch For 2019: SPDR Wells Fargo Preferred Stock ETF (PSK)

Advisors’ Opinion:

  • [By Max Byerly]

    PrairieSky Royalty Ltd (TSE:PSK) has earned a consensus recommendation of “Buy” from the twelve brokerages that are covering the stock, MarketBeat reports. Three investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average twelve-month price target among brokerages that have issued a report on the stock in the last year is C$32.99.

  • [By Ethan Ryder]

    PrairieSky Royalty (TSE:PSK)’s share price reached a new 52-week high during mid-day trading on Monday . The company traded as high as C$28.50 and last traded at C$28.40, with a volume of 395241 shares changing hands. The stock had previously closed at C$28.32.

  • [By Shane Hupp]

    The firm also recently declared a monthly dividend, which was paid on Thursday, February 7th. Shareholders of record on Monday, February 4th were given a $0.20 dividend. This represents a $2.40 annualized dividend and a yield of 5.76%. The ex-dividend date was Friday, February 1st.

    TRADEMARK VIOLATION NOTICE: “SPDR Wells Fargo Preferred Stock ETF (PSK) Shares Sold by Regal Investment Advisors LLC” was reported by Ticker Report and is the property of of Ticker Report. If you are accessing this article on another domain, it was stolen and republished in violation of United States & international copyright & trademark legislation. The legal version of this article can be read at https://www.tickerreport.com/banking-finance/4139767/spdr-wells-fargo-preferred-stock-etf-psk-shares-sold-by-regal-investment-advisors-llc.html.

    About SPDR Wells Fargo Preferred Stock ETF

  • [By Shane Hupp]

    LPL Financial LLC decreased its position in shares of SPDR Wells Fargo Preferred Stock ETF (NYSEARCA:PSK) by 23.2% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 138,573 shares of the company’s stock after selling 41,937 shares during the quarter. LPL Financial LLC’s holdings in SPDR Wells Fargo Preferred Stock ETF were worth $6,021,000 as of its most recent filing with the SEC.

  • [By Max Byerly]

    SPDR Wells Fargo Preferred Stock ETF (NYSEARCA:PSK) announced a monthly dividend on Monday, September 3rd, Wall Street Journal reports. Investors of record on Wednesday, September 5th will be given a dividend of 0.20 per share on Monday, September 10th. This represents a $2.40 annualized dividend and a dividend yield of 5.51%. The ex-dividend date of this dividend is Tuesday, September 4th.

Top 10 Medical Stocks To Watch For 2019: OSI Systems, Inc.(OSIS)

Advisors’ Opinion:

  • [By Max Byerly]

    Clearline Capital LP lessened its position in OSI Systems, Inc. (NASDAQ:OSIS) by 62.1% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 51,099 shares of the technology company’s stock after selling 83,849 shares during the period. OSI Systems comprises 2.6% of Clearline Capital LP’s portfolio, making the stock its 15th largest holding. Clearline Capital LP’s holdings in OSI Systems were worth $3,951,000 at the end of the most recent reporting period.

  • [By Joseph Griffin]

    Xilinx (NASDAQ:XLNX) and OSI Systems (NASDAQ:OSIS) are both computer and technology companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, profitability, institutional ownership, valuation and earnings.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on OSI Systems (OSIS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Watch For 2019: Golden Entertainment, Inc.(GDEN)

Advisors’ Opinion:

  • [By Logan Wallace]

    Shares of Golden Entertainment Inc (NASDAQ:GDEN) have received a consensus rating of “Hold” from the seven ratings firms that are presently covering the firm, Marketbeat Ratings reports. Two analysts have rated the stock with a sell rating, one has given a hold rating and three have assigned a buy rating to the company. The average 1 year price target among brokerages that have updated their coverage on the stock in the last year is $36.67.

  • [By Logan Wallace]

    Golden Entertainment Inc (NASDAQ:GDEN) shares traded up 7.2% during mid-day trading on Tuesday . The company traded as high as $25.31 and last traded at $25.29. 501,759 shares traded hands during mid-day trading, an increase of 47% from the average session volume of 341,759 shares. The stock had previously closed at $23.59.

  • [By Shane Hupp]

    News coverage about Golden Entertainment (NASDAQ:GDEN) has been trending somewhat positive on Thursday, Accern Sentiment Analysis reports. Accern identifies positive and negative news coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Golden Entertainment earned a news sentiment score of 0.23 on Accern’s scale. Accern also assigned headlines about the company an impact score of 45.5212527362401 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

Top 10 Medical Stocks To Watch For 2019: Shenandoah Telecommunications Co(SHEN)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Shenandoah Telecommunications (SHEN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Shenandoah Telecommunications (SHEN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    WINTON GROUP Ltd purchased a new stake in Shenandoah Telecommunications (NASDAQ:SHEN) during the first quarter, Holdings Channel reports. The firm purchased 24,122 shares of the utilities provider’s stock, valued at approximately $868,000.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Shenandoah Telecommunications (SHEN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Shenandoah Telecommunications (SHEN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Watch For 2019: ESSA Pharma Inc.(EPIX)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on ESSA Pharma (EPIX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on ESSA Pharma (EPIX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Get a free copy of the Zacks research report on ESSA Pharma (EPIX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

     

    Losers
    Heat Biologics, Inc. (NASDAQ: HTBX) shares tumbled 48.59 percent to close at $1.275 on Thursday after the company priced its $18,000,000 public offering.
    InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 38.77 percent to close at $8.26 on Thursday.
    Check-Cap Ltd. (NASDAQ: CHEK) shares tumbled 27.43 percent to close at $8.81.
    Achaogen, Inc. (NASDAQ: AKAO) dropped 24.76 percent to close at $11.06 in reaction to a disappointing update from an FDA AdCom panel. The FDA panel voted favorably for the company's Plazcomicin for treatment of adults with complicated urinary tract infections, but also voted against the therapy to be used as a treatment for bloodstream infections.
    Anika Therapeutics, Inc. (NASDAQ: ANIK) shares declined 24.68 percent to close at $34.80 after the company posted downbeat quarterly results.
    LSC Communications, Inc. (NASDAQ: LKSD) shares fell 24.22 percent to close at $12.64 following wider-than-expected Q1 loss.
    Cardinal Health, Inc. (NYSE: CAH) fell 21.42 percent to close at $50.80 following downbeat quarterly profit.
    Horizon Global Corporation (NYSE: HZN) dropped 20.42 percent to close at $6.00 following downbeat quarterly earnings.
    Hornbeck Offshore Services, Inc. (NYSE: HOS) slipped 20.11 percent to close at $2.90 following wider-than-expected Q1 loss.
    Esperion Therapeutics, Inc. (NASDAQ: ESPR) fell 19.28 percent to close at $36.93. Esperion Therapeutics stock lost roughly a third of its value Wednesday after the company reported mixed Phase III results for its leading drug candidate, bempedoic acid. JP Morgan downgraded Esperion Therapeutics from Neutral to Underweight.
    Laredo Petroleum, Inc. (NYSE: LPI) declined 17.77 percent to close at $8.98 after the company reported weaker-than-expected Q1 earnings.
    The Habit Restaurants, Inc. (NASDAQ: HABT) dipped 16.1 percent to close at $8.60 after the company reported downbeat quarterly results.
    Arcadia Biosciences, Inc. (N